Corrigendum to “PDGFB as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor”

Maria C. Pazos, Gonzalo Sequeira, Sebastian Bocchicchio, Maria May, Dalhia Abramovich, Fernanda Parborell, Marta Tesone, Griselda Irusta. J Cell Physiol 2018 Aug;233(8):5949-5961. 10.1002/jcp.26404. Epub 2018 Feb 27

In the original version of this article, the authors mistakenly used the wrong image to display the “control” panel in Figure 2b, resulting in a duplication with the “DAPT” panel depicting cleaved caspase-3 staining in Figure 3. The correct Figure 2b is presented below.

Additionally, the legend for Figure 1 is corrected to (changes in bold):

PDGFB treated tumor growth and inmunohistochemical analysis of ovarian xenograft tumors. (a) SKOV3 cells were inoculated in female nude mice. When tumors were palpable the animals received rec-PDGFB as treatment or saline solution (control) as described in Material and Methods section. Tumor size was measured in both groups. The variable was analyzed using Student's t test. No statistical difference was found between groups. (b–e) show hematoxylin and eosin stained sections of each tumor belonging to all experimental groups (control, rec-PDGFB, DAPT, and DAPT+rec-PDGFB). Scale bars: 20 μm in ×10 magnification pictures and 50 μm in ×40 magnification insets. Note that insets do not always correspond to the same histological section shown at ×10 magnification.

This correction doesn't change the results and conclusions. The authors apologize for any confusion these errors may have caused.